HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 1 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $736,715 | +12.6% | 6,368 | +0.1% | 0.01% | +16.7% |
| Q2 2023 | $654,434 | -5.3% | 6,363 | +0.5% | 0.01% | -14.3% |
| Q1 2023 | $691,294 | +72.4% | 6,334 | -2.3% | 0.01% | +40.0% |
| Q3 2022 | $401,000 | -94.2% | 6,481 | -92.6% | 0.01% | -91.9% |
| Q2 2022 | $6,940,000 | +47.4% | 87,018 | +94.5% | 0.06% | +72.2% |
| Q1 2022 | $4,707,000 | -39.3% | 44,740 | -37.8% | 0.04% | -37.9% |
| Q4 2021 | $7,749,000 | -38.1% | 71,914 | -37.0% | 0.06% | -27.5% |
| Q3 2021 | $12,509,000 | +108.6% | 114,196 | +78.3% | 0.08% | +53.8% |
| Q2 2021 | $5,996,000 | +10.3% | 64,040 | +8.5% | 0.05% | 0.0% |
| Q1 2021 | $5,434,000 | +44.2% | 59,043 | +13.4% | 0.05% | +33.3% |
| Q4 2020 | $3,768,000 | +383.7% | 52,056 | +419.3% | 0.04% | +290.0% |
| Q3 2020 | $779,000 | +48.7% | 10,025 | +6.4% | 0.01% | +42.9% |
| Q2 2020 | $524,000 | +87.8% | 9,424 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $279,000 | -13.1% | 9,424 | +6.1% | 0.01% | 0.0% |
| Q4 2019 | $321,000 | – | 8,879 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
| Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
| Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
| Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
| Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
| Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
| 1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
| Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
| Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
| Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |